Analysts have identified a common factor among the three firms that prompted investors to lap up their shares their relatively low valuations over the past few months.
Billionaire Mukesh Ambani’s group is getting into genetic mapping, looking to make a health care trend led by disruptive US startups like 23andMe more affordable and widespread in India’s growing consumer market.
The National Pharmaceutical Pricing Authority has finalised the ceiling prices of 97 scheduled formulations and approved revised ceiling prices of 31 formulations that are a part of the National List of Essential Medicines.
Under the revised Schedule I of the Drugs (Prices Control) Order, or DPCO, the NPPA notified the calculation and the maximum ceiling limit for prices that could be charged for listed essential medicines, according to the release issued on Jan. 6.